Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer
This study has been terminated.
(funding terminated)
Sponsor:
Hoosier Oncology Group
Collaborators:
Indiana University School of Medicine
Emory University
Information provided by:
Hoosier Oncology Group
ClinicalTrials.gov Identifier:
NCT01232881
First received: November 1, 2010
Last updated: April 27, 2011
Last verified: April 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | November 2010 |
| Primary Completion Date: | November 2010 (Final data collection date for primary outcome measure) |